EV1 DEVELOPMENT OF A GUIDANCE FOR INCLUDING PATIENT-REPORTED OUTCOMES (PROS) IN POST-APPROVAL CLINICAL TRIALS OF ONCOLOGY DRUGS FOR COMPARATIVE EFFECTIVENESS RESEARCH (CER)
- 31 May 2011
- journal article
- abstracts
- Published by Elsevier BV in Value in Health
- Vol. 14 (3), A10
- https://doi.org/10.1016/j.jval.2011.02.060